PALO ALTO, CA--(Marketwire - December 04, 2007) - Hathaway Corporation (PINKSHEETS: HWYI) announced that its subsidiary, Diabetes Detection, Inc. (DDI), has been successful in signing two of the leading physicians and clinical researchers of Neuropathy and Diabetes treatments, for its Scientific Advisory Board. The highly respected physicians, who are authors of numerous research studies, papers and textbooks, have played significant leadership roles with various international Diabetes-related associations, including holding a past chairmanship of the American Diabetes Association. They have been responsible for, among other things, shaping the ADA’s official position on Diabetic Neuropathies, and are strong and outspoken proponents for vibration testing for Neuropathy, the basis for DDI’s technology.
